Oliver Lagore Vanvalin Investment Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-129
| Closed | -$7.52K | – | 872 |
|
|
2023
Q3 | $7.52K | Hold |
129
| – | – | ﹤0.01% | 481 |
|
|
2023
Q2 | $7.62K | Buy |
129
+3
| +2% | +$177 | ﹤0.01% | 511 |
|
|
2023
Q1 | $7.43K | Hold |
126
| – | – | ﹤0.01% | 430 |
|
|
2022
Q4 | $7.86K | Hold |
126
| – | – | ﹤0.01% | 393 |
|
|
2022
Q3 | $7K | Hold |
126
| – | – | ﹤0.01% | 390 |
|
|
2022
Q2 | $8K | Hold |
126
| – | – | ﹤0.01% | 361 |
|
|
2022
Q1 | $8K | Buy |
+126
| New | +$8K | 0.01% | 355 |
|